Question from Deputy Ken O'Flynn - PQ 33752-26
Deputy O'Flynn asked about the proportion of reimbursement applications for orphan or rare disease medicines that have been completed within 180 days.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about the proportion of reimbursement applications for orphan or rare disease medicines that have been completed within 180 days.
Deputy O'Flynn asked about the safeguarding protocols for clinicians when assessing minors presenting with gender-related distress. Read the HSE response.
Deputy O'Flynn asked about compliance with clinical standards in gender-related care for minors. Read the HSE response.
Deputy O'Flynn asked about the number of minors referred, assessed or treated under gender-related pathways in the past 5 years. Read the HSE response.
Deputy O'Flynn asked if post-operative outcomes, complications, or follow-up requirements are tracked for patients funded under the Treatment Abroad Scheme.
Deputy O'Flynn asked if data is collected on procedures undertaken primarily for quality-of-life reasons. Read the HSE response.
Deputy O'Flynn asked about a national data system , audit framework and governance structure for gender-related healthcare pathways for minors.
Deputy O'Flynn asked if any clinical audits of gender-related services for minors has been commissioned. Read the HSE response.
Deputy Nolan asked about the number of people who are living with Parkinson's Disease in Laois/Offaly. Read the HSE response.
Deputy O'Flynn asked if decisions to approve funding under the Treatment Abroad Scheme are subject to an independent clinical review. Read the HSE response.